Patent & IP news for April 28, 2012

Guest Post: The story behind Ranbaxy's new drug from spicyipindia.blogspot.com

Pursuant to my last post on Ranbaxy’s new anti-malarial drug, I received a few comments indicating a certain level of confusion about the exact nature of Ranbaxy’s invention. I therefore requested Akshat Rathi ...

Share via E–mail | Twitter | Facebook

The Role of Submission Limits in Timely Completion of Supplemental Examination from www.uspto.gov

This entry in our series on implementation of the America Invents Act (AIA) focuses on the proposed rules for supplemental examination.

The supplemental examination procedure was designed to provide patentees with a quick and decisive ...

Share via E–mail | Twitter | Facebook

Apple and Samsung CEOs to meet on May 21 and 22 for settlement talks in San Francisco court from www.fosspatents.com

On April 17, I already reported on the fact that Apple and Samsung agreed, under soft pressure from Judge Lucy Koh of the United States District Court for the Northern District of California, to meet ...

Share via E–mail | Twitter | Facebook

List of 50+ Apple-Samsung lawsuits in 10 countries from www.fosspatents.com

Apple and Samsung will meet in San Francisco on May 21 and 22 to talk settlement. Settling this massively-escalated, planet-spanning dispute will be a Herculean task:

All in all, the parties have filed approximately 50 ...

Share via E–mail | Twitter | Facebook

ACTA In Parliament: Kill Or Repair? from www.ip-watch.org

Opponents and proponents of the Anti-Counterfeiting Trade Agreement (ACTA) in the European Parliament have positioned themselves in meetings of several committees preparing opinions. Related Articles:

• European Parliament Rejects Referral Of ACTA To EU High Court ...

Share via E–mail | Twitter | Facebook